Beta-Thalassemia [DS:H00228] Graft rejection [DS:H00083] Adenocarcinoma of the breast or ovary [DS:H00031H00027] Papillary carcinoma of the urinary bladder [DS:H00022]
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AC Ethylene imines
L01AC01 Thiotepa
D00583 Thiotepa (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Antineoplastics
Alkylating Agents
Alkylating Agents, Other
Thiotepa
D00583 Thiotepa (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
421 Alkylating agents
4212 Ethyleneimines
D00583 Thiotepa (JAN/USP/INN)
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG01723 Ethylene imine
DG01722 Thiotepa type ethylene imine
D00583 Thiotepa
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00583
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00583